Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2014 Oct 16;124(16):2613-4.
doi: 10.1182/blood-2014-06-582122.

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

Florence Beckerich  1 , Christophe Hézode  2 , Christine Robin  1 , Jean-Louis Beaumont  3 , Eric Gautier  4 , Sébastien Maury  1 , Catherine Cordonnier  1
Affiliations
Case Reports

New nucleotide polymerase inhibitors to rapidly permit hematopoietic stem cell donation from a positive HCV-RNA donor

Florence Beckerich et al. Blood. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Evolution of the HCV-RNA viral load (log) over time in a stem cell transplantation donor treated with sofosbuvir and ribavirin before stem cell collection.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Shuhart MC, Myerson D, Childs BH, et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood. 1994;84(9):3229–3235. - PubMed
    1. Ljungman P, Locasciulli A, de Soria VG, et al. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Long-term follow-up of HCV-infected hematopoietic SCT patients and effects of antiviral therapy. Bone Marrow Transplant. 2012;47(9):1217–1221. - PubMed
    1. Tomblyn M, Chen M, Kukreja M, et al. No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation. Transpl Infect Dis. 2012;14(5):468–478. - PMC - PubMed
    1. Peffault de Latour R, Lévy V, Asselah T, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood. 2004;103(5):1618–1624. - PubMed
    1. Vance EA, Soiffer RJ, McDonald GB, Myerson D, Fingeroth J, Ritz J. Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. Transplantation. 1996;62(9):1358–1360. - PubMed